Myelopoiesis in Myelodysplasia Evaluated by Multiparameter Flow Cytometry

References

• Bennett J. M., Catovsky D., Daniel M. T., Flandrian G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Koeffler P., Cline M. J., Golde D. W. Erythropoiesis in preleukemia. Blood 1986; 51: 1013–1019
   Google Scholar
• Coiffier B., Adeleine P., Viala J. J., Bryon P. A., FiÉRe D., Gentilhomme O., Vuvan H. Dysmyelopoietic syndromes. Cancer 1983; 52: 83–90
   PubMed Web of Science ®Google Scholar
• Economopoulos T., Papageorgiou E., Stathakis N., Asprou N., Karmas P., Dervenoulas J., Bouronikou H., Chalevelakis G., Raptis S. Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony stimulating factor (GM-CSF) or GM-CSF combined with low-dose cytosine arabinoside. Eur. J. Haematol. 1992; 49: 138–142
   PubMed Web of Science ®Google Scholar
• Kerkhofs H., Hermans J., Haak H. L., Leeksma C. H. W. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br. J. Haematol. 1987; 65: 73–81
   PubMed Web of Science ®Google Scholar
• Baumann I., Harms H., Kuse R., Wilms K., Muller-Hermelink H. K. Differentiation of blast cells in MDS and Acute Myeloid Leukemia by automated image analysis. Annals Haematol. 1992; 65, 20 (abstr)
   Google Scholar
• Hokland P., Kerndrup G., Griffin J. D., Ellegaard J. Analysis of leucocyte differentiation antigens in blood and bone marrow from preleukemia (refractary anemia) patients using monoclonal antibodies. Blood 1986; 67: 898–902
   PubMed Web of Science ®Google Scholar
• Clark R. E., Smith S. A., Jacobs A. Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid. J. Clin. Pathol. 1987; 40: 652–656
   PubMed Web of Science ®Google Scholar
• Kerndrup G., Bendix-Hansen K., Pedersen B., Ellegaard J., Hokland P. Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data. Eur. J. Haematol. 1988; 41: 368–374
   PubMed Web of Science ®Google Scholar
• Kristensen J. S., Hokland P. Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br. J. Haematol. 1990; 74: 270–276
   PubMed Web of Science ®Google Scholar
• Guyotat D., Campos L., Thomas X., Vila L., Shi Z-H. Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns. Am. J. Hematol. 1990; 34: 26–31
   PubMed Web of Science ®Google Scholar
• Terstrappen L. W. M. M., Loken M. R. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assesed by multi-dimensional flow cytometry. Analyt. Cell Pathol. 1990; 2: 229–240
   PubMed Web of Science ®Google Scholar
• Terstrappen L. W. M. M., Safford M., KÖNemann S., Loken M. R., Zurlutter K., BÜChner T., Hiddemann W., WÖRmann B. Flow cytometric charracterization of acute myeolid leukemia. Part II. phenotypic heterogeneity at diagnosis. Leukemia 1991; 5: 757–767
   Web of Science ®Google Scholar
• Koeffler H. P. Myelodysplastic Syndromes. Seminars Hematol. 1986; 23: 284–299
   PubMed Web of Science ®Google Scholar
• Reizenstein P., LagerlÖF B., SkÅRberg K. O., Kock Y., Jores S. Alterations in Erythropoiesis Preceding Leukemia. Acta Haematologica 1975; 54: 152–156
   PubMed Web of Science ®Google Scholar
• Singh A. K., Shinton N. K., Williams J. D. F. Ferrokinetic Abnormalities and their Significance in Patients with Sideroblastic Anemia. Br. J. Haematol. 1970; 18: 67–77
   PubMed Web of Science ®Google Scholar
• May S. J., Smith S. A., Jacobs A., Williams A., Bailey-Wood R. The Myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification. Br. J. Haematol. 1985; 59: 311–319
   PubMed Web of Science ®Google Scholar
• Hast R., Reizenstein P. Studies on human preleukemia. Scand. J. Haematol. 1977; 19: 347–354
   PubMedGoogle Scholar
• Seigeurin D., Hollard D. Use of tritiated thymidine-labelling index of myeloblast-promyelocyte pool for the identification of leukemic population in oligoblastic leukemia. Acta Haematol. 1981; 66: 181–186
   PubMed Web of Science ®Google Scholar
• Karsdorf A., Dresch C., Metral J., Najean Y. Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemias. Leukemia Res. 1983; 7: 279–286
   PubMed Web of Science ®Google Scholar
• DÖRmer P., Hegemann F., Brinkmann W. Proliferation and production of hemopoietic cells in two stage of disease: Preleukemia and overt leukemia. Klinische Wochensch. 1976; 54: 461–466
   PubMedGoogle Scholar
• Dresch C., Faille A., Poirier O., Balitrand N., Najean Y. Bone marrow cell kinetic and culture in chronic and subacute myelomonocytic leukemia. Physiopathological interpretation and prognostic importance. Leukemia Res. 1979; 4: 129–142
   Web of Science ®Google Scholar
• Montecucco C., Riccardi A., Traversi E., Giordano P., Mazzini G., Ascari E. Proliferative Activity of Bone Marrow Cells in Primary Dysmyelopoietic (Preleukemic) Syndromes. Cancer 1983; 52: 1190–1195
   PubMed Web of Science ®Google Scholar
• Montecucco C., Riccardi A., Traversi E., Danova M., Ucci G., Mazzini G., Giordano P. Flow Cytometric DNA content in Myelodysplastic Syndromes. Cytometry 1983; 4: 238–243
   PubMedGoogle Scholar
• Peters S. W., Clark R. E., Hoy T. G., Jacobs A. DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS). Br. Haematol. 1986; 62: 239–245
   PubMed Web of Science ®Google Scholar
• Jensen I. M., Kristensen J. S., Thomsen M., Ellegaard J., Hokland P. Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: The value of both internal and external standards. Analyt. Cell. Pathol. 1993; 5: 213–223
   PubMed Web of Science ®Google Scholar
• Jensen I. M., Ellegaard J., Hokland P. Differences in the relative DNA content between peripheral blood and bone marrow subpopulations—Consequenses for DNA index calculations. Cytometry 1993; 14: 936–942
   PubMedGoogle Scholar
• Griffin J. D., Ritz J., Nadler L. M., Schlossman S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Investig. 1981; 68: 932–941
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Linch D., Sabbath K., Larcom P., Schlossman S. F. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leukemia Res. 1984; 8: 521–534
   PubMed Web of Science ®Google Scholar
• BØYum A. Isolation of mononuclear cells and granolocytes from human blood. Scand. J. Clin. Lab. Investig. 1968; 21 (Suppl.): 77–89
   Web of Science ®Google Scholar
• Andreasen R., Killmann S-A., Olsson L. A monoclonal antibody (Nat 9 II.3F-6F) that identifies a differentiation antigen on human myeloid cells. Leukemia Res. 1984; 9: 1161–1170
   Web of Science ®Google Scholar
• Knapp W., DÖRken B., Gilks W. R., Rieber E. P., Schmidt R. E., Stein H., Von Dem Borne A. E. G. K. Leucocyte typing IV. White cell differentiation antigens. Oxford University press, Oxford 1989; 784–785
   Google Scholar
• Bagwell C. B., Baker D., Whetstone S., Munson M., Hitchcox S., Ault K. A., Lowett E. J. A simple and rapid method for determining the linearity of a flow cytometer amplification system. Cytometry 1989; 10: 689–694
   PubMedGoogle Scholar
• Jensen I. M. Multiparameter FCM in MDS. Thesis (ISBN 87-985120-0-5). Århus University, Denmark 1994
   Google Scholar
• Jensen I. M., Hokland P. The proliferative activity of myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry. Br. J. Haematol. 1994; 87: 477–482
   PubMed Web of Science ®Google Scholar
• Jensen I. M., Hokland M., Hokland P. A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flowcytometry. Leukemia Res. 1993; 17: 839–846
   PubMed Web of Science ®Google Scholar
• NÜSsler V., Sauer H., Pelka-Fleischer R., HÖLzel D., Wilmanns W. Clinical biochemical and cytokinetic parameter for distinguishing smouldering and rapidly proliferating variants of acute leukemia. Eur. J. Haematol. 1990; 45: 19–25
   PubMed Web of Science ®Google Scholar
• Brons P., Pennings A., Haanen C., Wessels H., Boezeman J. S-phase DNA content and aneuploidy of immunophenotypic defined subpopulations in acute myeloid leukemia determined by multi-parameter flow cytometry. Leukemia Res. 1991; 15: 827–835
   PubMed Web of Science ®Google Scholar
• Baumann M. A., Keller R. H., McFadden P. W., Libnoch J. A., Patrick C. A. Myeloid cell surface phenotype in myelodysplasia: evidence for abnormal persistence of an early myeloid antigen. Am. J. Hemat. 1986; 22: 251–257
   PubMed Web of Science ®Google Scholar
• Goselink H. M., Williams D. E., Fibbe W. E., Wessels H. W., Geoffrey C., Beverstock G. C., Willernze R., Falkenburg J. H. F. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood 1992; 80: 750–757
   PubMed Web of Science ®Google Scholar
• Tricot G., De Wolf-Peeters C., Hendriks B., Verwilghen R. L. Bone marrow histology in myelodysplastic syndromes II. Prognostic significance of abnormal localization of immature precursors in MDS. Br. J. Haematol. 1984; 58: 217–225
   PubMed Web of Science ®Google Scholar
• Cazzola M., Barosi G., Berzuini C., Dacco M., Orlandi E., Stefanelli M., Ascari E. Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br. J. Haematol. 1982; 50: 55–62
   PubMed Web of Science ®Google Scholar
• Mangi M. H., Mufti G. J. Primary Myelodysplastic syndromes: Diagnostic and prognostic significance of immunohisto-chemical assesment of human bone marrow biopsies. Blood 1992; 79: 198–206
   PubMed Web of Science ®Google Scholar
• Tertrappen L. W. M. M., Hollander Z., Meiners H., Loken M. R. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J. Leucocyte Biol. 1990; 48: 138–148
   PubMed Web of Science ®Google Scholar
• Sieff C. A., Emerson S. G., Donabue R. E. Human recombinant granulocyte-macrophage colony-stimulating factor, a multilineage hematopoietin. Science 1985; 230: 1171–1173
   PubMed Web of Science ®Google Scholar
• Fleischmann J., Golde D. W., Weisbart R. H., Gasson J. C. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria in human neutrophils. Blood 1986; 68: 708–711
   PubMed Web of Science ®Google Scholar
• Ganser A., VÖLkers B., Greher F., Walther F., Hoelzer D. Recombinant human granulocyte-macrophage colony stimulating factor in patients with myelodysplastic syndromes—a phase I/II trial. Onkologie 1988; 11: 53–55
   PubMed Web of Science ®Google Scholar
• Verhof G., Berghe H. V. D., Boogaerts M. Cytogenetic effects on cells derived from patients with myelodysplastic syndromes during treatment with hemopoietic growth factors. Leukemia 1992; 6: 766–769
   PubMed Web of Science ®Google Scholar
• Greenberg P. Treatment of myelodysplastic syndromes with hemopoietic growth factors. Sem. Oncol. 1992; 19: 106–114
   PubMed Web of Science ®Google Scholar